Laurila Riikka, Parkkila Seppo, Isola Jorma, Kallioniemi Anne, Alarmo Emma-Leena
Institute of Biomedical Technology, University of Tampere and BioMediTech, Tampere, Finland.
Int J Clin Exp Pathol. 2013 Jun 15;6(7):1400-8. Print 2013.
Gremlin 1 and noggin are inhibitors of bone morphogenetic protein (BMP) signaling. They are vital during early development but their role in adult tissues has remained largely unresolved. The BMP signaling pathway has also been implicated in tumorigenesis, however with emphasis on the role of the ligands and receptors. We performed a concurrent survey of gremlin 1 and noggin protein expression in multiple normal and cancer samples, using immunohistochemistry on tissue microarrays containing 96 samples from 34 different normal organs/tissue sites and 208 samples of 34 different tumor types. In majority of both normal and tumor samples, gremlin 1 and noggin expression was negative or weak. However, normal stomach and skin demonstrated distinct gremlin 1 and noggin expression indicating a role in adult tissues. Likewise, strong expression of both antagonists was detected in Leydig cells of testis. In the tumor panel, the expression patterns were more variable but elevated BMP antagonist expression was detected for the first time in few cases, such as glioblastoma, hepatocellular carcinoma and diffuse B-cell lymphoma for gremlin 1 and renal granular cell tumor and thyroid papillary carcinoma for noggin. Even though gremlin 1 and noggin were not widely expressed in adult tissues, in a subset of organs their expression pattern indicated a potential role in normal tissue homeostasis as well as in malignancies.
Gremlin 1和头蛋白是骨形态发生蛋白(BMP)信号通路的抑制剂。它们在早期发育过程中至关重要,但其在成体组织中的作用在很大程度上仍未明确。BMP信号通路也与肿瘤发生有关,不过主要侧重于配体和受体的作用。我们使用免疫组织化学方法,对包含来自34个不同正常器官/组织部位的96个样本以及34种不同肿瘤类型的208个样本的组织芯片,同时检测了gremlin 1和头蛋白在多个正常和癌症样本中的蛋白表达情况。在大多数正常和肿瘤样本中,gremlin 1和头蛋白的表达呈阴性或弱阳性。然而,正常胃组织和皮肤组织呈现出独特的gremlin 1和头蛋白表达,表明它们在成体组织中发挥作用。同样,在睾丸的间质细胞中检测到这两种拮抗剂的强表达。在肿瘤样本组中,表达模式更具变异性,但首次在少数病例中检测到BMP拮抗剂表达升高,例如gremlin 1在胶质母细胞瘤、肝细胞癌和弥漫性B细胞淋巴瘤中,头蛋白在肾颗粒细胞瘤和甲状腺乳头状癌中。尽管gremlin 1和头蛋白在成体组织中并非广泛表达,但在一部分器官中,它们的表达模式表明其在正常组织稳态以及恶性肿瘤中可能发挥作用。